Financial Summary (All financials)
In millions, except per share items | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 |
Revenues | 0.0 | 0.0 | 0.0 | 0.1 | 2,996.0 |
Revenue growth | | | -100.0% | -100.0% | |
Cost of goods sold | 0.0 | 0.0 | 0.0 | 0.0 | 17,404.0 |
Gross profit | 0.0 | 0.0 | 0.0 | 0.0 | -14,408.0 |
Gross margin | | | | 65.9% | -480.9% |
Selling, general and administrative | 0.0 | 0.0 | 0.0 | | |
Sales and marketing | 0.0 | 0.0 | 0.0 | 0.0 | 11,772.0 |
Research and development | | | | 0.0 | 8,935.0 |
General and administrative | 0.0 | 0.0 | 0.0 | 0.0 | 2,475.0 |
EBIT | 0.0 | 0.0 | 0.0 | 0.0 | 8,977.0 |
EBIT margin | | | | 16.1% | 299.6% |
Pre-tax income | 0.0 | 0.0 | 0.0 | 0.0 | 8,134.0 |
Income taxes | 0.0 | 0.0 | 0.0 | 0.0 | 1,106.0 |
Tax rate | | | | 14.3% | 13.6% |
Earnings from continuing ops | | | | 0.0 | 7,028.0 |
Earnings from discontinued ops | | | | | 10,766.0 |
Net income | 0.0 | 0.0 | 0.0 | 0.0 | 17,794.0 |
Net margin | | | | 13.0% | 593.9% |
|
Diluted EPS | | | $0.00 | $2.82 | $2.92 |
Shares outstanding (diluted) | | | 0.0 | 0.0 | 2,404.6 |
|
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|